Bridgewater Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-98,086
Closed -$3.6M 930
2022
Q4
$3.6M Buy
+98,086
New +$3.88M 0.02% 425

Other funds holding SYNH

Bridgewater Associates's SYNH Position: Q1 2023 in Review

Bridgewater Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 98,086 shares — an estimated $3.6M sold.

Bridgewater Associates first reported a position in SYNH in Q4 2022 and held it in 1 quarter. The position peaked at $3.6M in Q4 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Bridgewater Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bridgewater Associates sold 98,086 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $3.6M.
  • Bridgewater Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Bridgewater Associates's Syneos Health, Inc. Class A Common Stock position peaked at $3.6M in Q4 2022.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.